MA
VYNT

MUFG Americas’s Vyant Bio, Inc. Common Stock VYNT Stock Holding History

MUFG Americas’s Portfolio VYNT Stock Details VYNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-108
Closed -$328K – 1222
2013
Q3 		$328K Buy
+108
New +$185K 0.01% 440

Other funds holding VYNT

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
TCM
Timpani Capital Management Milwaukee, Wisconsin $209M AUM 62.15% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sterneck Capital Management Kansas City, Missouri $223M AUM 17.15% 1-Year Est. Return
GMCM
Gruber & McBaine Capital Management San Francisco, California $369M AUM 12.23% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
SIM
SSI Investment Management Los Angeles, California $1.45B AUM 5.8% 1-Year Est. Return
TC
TFS Capital West Chester, Pennsylvania $255M AUM 32.31% 1-Year Est. Return
RIL
Rothschild Investment LLC Chicago, Illinois $1.91B AUM 24.37% 1-Year Est. Return

MUFG Americas's VYNT Position: Q4 2013 in Review

MUFG Americas sold out of Vyant Bio, Inc. Common Stock (VYNT) in Q4 2013, closing a stake of 108 shares — an estimated $328K sold.

MUFG Americas first reported a position in VYNT in Q3 2013 and held it in 1 quarter. The position peaked at $328K in Q3 2013. 29 funds tracked by Wall St. Rank hold VYNT as of Q4 2013.

  • MUFG Americas reported no remaining Vyant Bio, Inc. Common Stock position as of Q4 2013 after selling out during the quarter.
  • MUFG Americas sold 108 Vyant Bio, Inc. Common Stock shares in Q4 2013, an estimated $328K.
  • MUFG Americas first reported a position in Vyant Bio, Inc. Common Stock in Q3 2013 and held it in 1 quarter.
  • MUFG Americas's Vyant Bio, Inc. Common Stock position peaked at $328K in Q3 2013.
  • 29 funds tracked by Wall St. Rank held Vyant Bio, Inc. Common Stock as of Q4 2013.

Based on MUFG Americas's 13F filing for Q4 2013, filed 11 Feb 2014.